09:59 ET -- Johnson & Johnson is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Johnson & Johnson beat second-quarter profit and sales expectations, while providing a mixed full-year outlook. Income fell to $4.69 billion, or $1.93 a share, from $5.14 billion, or $2.05 a share, in the same period a year ago. Adjusted earnings per share rose to $2.82 from $2.56 and beat the FactSet consensus of $2.71. Sales grew 4.3% to $22.45 billion, above the FactSet consensus of $22.33 billion. The company cut its guidance for adjusted EPS to $9.97 to $10.07 from $10.57 to $10.72 but raised its outlook for operational sales to $89.2 billion to $89.6 billion from $88.7 billion to $89.1 billion. Dow Jones & Co. owns Factiva. (chris.wack@wsj.com)


(END) Dow Jones Newswires

07-17-24 1014ET